학술논문

Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial
Document Type
Article
Source
In: Cancer. (Cancer, 15 December 2022, 128(24):4203-4212)
Subject
Language
English
ISSN
10970142
0008543X